Sonoma Pharmaceuticals (SNOA) Divestments (2015 - 2020)

Sonoma Pharmaceuticals (SNOA) recorded quarterly Divestments of $610000.0 in Q2 2020, down 86.56% quarter-over-quarter from $4.5 million in Q2 2015.

Sonoma Pharmaceuticals (SNOA) Divestments (2015 - 2020) Analysis & Trends

Sonoma Pharmaceuticals' Divestments history runs 2 years deep, the most recent figure standing at $610000.0 for Q2 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 42.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn -
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 63.20 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn -
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 24.21 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -
10 Sonoma Pharmaceuticals 1.90 Mn -659,569.98 1.65 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2020 610,000.00
Jun 30, 2015 4.54 Mn